A Validated Proteomic Signature of Basal-like Triple-Negative Breast Cancer Subtypes Obtained from Publicly Available Data

These findings suggest the existence of novel molecular signatures that could improve TNBC classification, prognosis, and potential therapeutic targeting.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2025-08-08
DOI
https://doi.org/10.3390/cancers17162601
Citations
1
Primary Topic
Molecular Biology Techniques and Applications
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Validated Proteomic Signature of Basal-like Triple-Negative Breast Cancer Subtypes Obtained from Publicly Available Data

Edoardo Saccenti, María Suárez‐Diez, Cristina Furlan
1 citations
Cancers
Molecular Biology Techniques and Applications
0.81
article

A Validated Proteomic Signature of Basal-like Triple-Negative Breast Cancer Subtypes Obtained from Publicly Available Data

Edoardo Saccenti, María Suárez‐Diez, Cristina Furlan
article en
1 citations

Abstract

These findings suggest the existence of novel molecular signatures that could improve TNBC classification, prognosis, and potential therapeutic targeting.

CancersVol. 17(16)
Wageningen University & Research (NL)
Good health and well-being
Openalex Percentile: Top 25%
Molecular Biology Techniques and Applications
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Validated Proteomic Signature of Basal-like Triple-Negative Breast Cancer Subtypes Obtained from Publicly Available Data — Edoardo Saccenti, María Suárez‐Diez, et al. · Cancers (2025) | TGRS Research Map | TGRS